Westlake Chemical Partners (WLKP) EBITDA (2013 - 2026)

Westlake Chemical Partners' EBITDA history runs 14 years deep, the most recent figure standing at $86.6 million for Q1 2026.

• Quarterly EBITDA rose 85.74% year-over-year to $86.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.5 million (up 5.14% YoY) and the FY2025 annual result came in at $319.6 million, down 18.15% from the prior year.
• EBITDA was $86.6 million for Q1 2026 at Westlake Chemical Partners, down from $89.8 million in the prior quarter.
• Across five years, EBITDA topped out at $109.7 million in Q3 2024 and bottomed at $46.6 million in Q1 2025.
• A 5-year average of $88.4 million and a median of $91.2 million in 2025 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2025 — EBITDA sank 50.99% — and 2026, when it soared 85.74%.
• Westlake Chemical Partners' EBITDA stood at $95.3 million in 2022, then fell by 2.58% to $92.8 million in 2023, then declined by 0.85% to $92.0 million in 2024, then decreased by 2.46% to $89.8 million in 2025, then declined by 3.55% to $86.6 million in 2026.
• Business Quant data shows WLKP's EBITDA at $86.6 million in Q1 2026, $89.8 million in Q4 2025, and $92.0 million in Q3 2025.